Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Reiterates Buy Rating and Adjusts Price Target for Phreesia NYSE PHR

Elaine Mendonca by Elaine Mendonca
January 18, 2024
in Breaking News
0
Healthcare Services Stock Exchange
0
SHARES
11
VIEWS
Share on FacebookShare on Twitter

On January 18, 2024, Ryan MacDonald, an analyst at Needham, expressed his optimistic view on Phreesia (NYSE: PHR) by reiterating a Buy rating and maintaining a price target of $29. This reaffirmation of confidence in the company’s stock indicates the potential for upward movement. Although the price target has been adjusted from $40 to $29, the Buy recommendation showcases MacDonald’s belief in Phreesia’s future performance.

PHR Stock Performance Declines on January 18, 2024: A Detailed Analysis

PHR, a publicly traded company, experienced a decline in its stock performance on January 18, 2024. According to data sourced from CNN Money, the stock closed at $24.03, marking a decrease of $0.68 or 2.75% from the previous market close. Additionally, in after-hours trading, the stock dropped a further $0.20.

PHR Stock Performance on January 18, 2024: Mixed Revenue Growth and Net Income Decline

PHR Stock Performance on January 18, 2024: A Mixed Bag of Revenue Growth and Net Income Decline

On January 18, 2024, PHR stock experienced a mixed performance as the company’s revenue showed promising growth, while its net income declined.

Total revenue for PHR stood at $280.91 million for the past year, representing a substantial increase of 31.74% compared to the previous year. Additionally, the company’s total revenue also increased by 6.74% since the last quarter.

However, the picture is not entirely rosy, as PHR’s net income witnessed a decline. Over the past year, the company reported a net income of -$176.15 million, reflecting a decrease of 49.07% compared to the previous year. On a positive note, the net income increased by 13.13% since the last quarter.

The earnings per share (EPS) is another crucial metric to assess a company’s financial performance. PHR reported an EPS of -$3.36 for the past year, which is a decrease of 41.82% compared to the previous year. However, there was a slight improvement in the EPS since the last quarter, with a 15.42% increase.

Overall, the stock performance of PHR on January 18, 2024, showcased a mix of positive and negative indicators. While the company experienced significant revenue growth over the past year and quarter, the net income and EPS declined on a yearly basis. However, there was a slight improvement in net income and EPS since the last quarter, which may indicate that PHR is taking steps to address its profitability challenges.

Investors should carefully analyze these financial metrics and consider other factors, such as market conditions and industry trends, before making any investment decisions related to PHR stock. It is essential to assess the company’s long-term strategy, competitive positioning, and ability to adapt to changing market dynamics to make informed investment choices.

Tags: PHR
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Retail Market Capitalization

Introducing Club92 Dollar Generals Exclusive Home Fragrance Collection

Technology Robotics Trading online

Analysts Provide Mixed Ratings and Price Targets for Impinj NASDAQPI

CTVA stock news

Mixed Analyst Sentiments and Price Targets for Adobe NASDAQ ADBE

Recommended

Anticipating Navigator Holdings Quarterly Earnings Report Analysts Predict 030 EPS

2 years ago
Sandy Spring Stock

Sandy Spring Bancorp’s Final Chapter: A New Era Under Atlantic Union

3 months ago
Certara Stock

Certara Stock: Regulatory Milestone and Strong Fundamentals Fuel Recovery Hopes

6 months ago
Meta Stock

Meta Faces Mounting Pressure from Regulators and Strategic Shifts

2 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Tellurian Acquisition Finalized as Woodside Takes Control

Coherus BioSciences Forges Key Oncology Alliance with Janssen

TCG BDC Investors Await Key Financial Milestones

Navigating Change: Schnitzer Steel’s Digital and Structural Evolution

Akso Health Group Pivots to Oncology with Global Patient Initiative

Trending

Deluxe Stock
Analysis

Deluxe Stock Gains Momentum on Successful Fintech Transition

by Kennethcix
February 6, 2026
0

Deluxe Corporation is successfully shedding its legacy identity as a check-printing specialist. The company's strategic pivot toward...

Hydrofarm Holdings Inc Stock

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

February 6, 2026
Northeast Bancorp Stock

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

February 6, 2026
Vir Biotechnology Stock

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

February 6, 2026
Tellurian Stock

Tellurian Acquisition Finalized as Woodside Takes Control

February 6, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Deluxe Stock Gains Momentum on Successful Fintech Transition
  • Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches
  • Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com